US Patent 11753644 Compounds and methods for reducing IFNAR1 expression
Patent 11753644 was granted and assigned to Ionis Pharmaceuticals, Inc. on September, 2023 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
June 17, 2022
Date of Patent
September 12, 2023
Patent Applicant
Patent Application Number
17842960
Patent Citations
•••
Patent Inventor Names
Fredrik Carl Kamme
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11753644 Compounds and methods for reducing IFNAR1 expression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
